We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
-16.7%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$5.13B
(-23%)
Cap. Flow
-$794M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
494
New
36
Increased
156
Reduced
156
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$108M |
| 2 |
Visa
V
|
+$102M |
| 3 |
Mercado Libre
MELI
|
+$73M |
| 4 |
Enphase Energy
ENPH
|
+$58.6M |
| 5 |
Snowflake
SNOW
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$147M |
| 2 |
Y
Alleghany Corp
Y
|
+$137M |
| 3 |
Applied Materials
AMAT
|
+$116M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$115M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Industrials | 25.1% |
| 3 | Healthcare | 17.44% |
| 4 | Financials | 14.96% |
| 5 | Communication Services | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
426
DELISTED
Hologic
HOLX
| – | – |
-195,937
| Closed | -$15.1M |
|
427
Intuit
INTU
$89.9B
| – | – |
-16,554
| Closed | -$7.96M |
|
428
Jazz Pharmaceuticals
JAZZ
$15.9B
| – | – |
-100,000
| Closed | -$15.6M |
|
429
Mohawk Industries
MHK
$8.68B
| – | – |
-35,088
| Closed | -$4.36M |
|
430
Match Group
MTCH
$9.85B
| – | – |
-840,157
| Closed | -$91.4M |
|
431
MasTec
MTZ
$18.2B
| – | – |
-5,818
| Closed | -$507K |
|
|
NOVA
432
DELISTED
Sunnova Energy
NOVA
| – | – |
-8,791
| Closed | -$203K |
|
433
Ocular Therapeutix
OCUL
$2.36B
| – | – |
-37,790
| Closed | -$187K |
|
434
Oracle
ORCL
$414B
| – | – |
-38,791
| Closed | -$3.21M |
|
435
O'Reilly Automotive
ORLY
$69.9B
| – | – |
-64,965
| Closed | -$2.97M |
|
436
Protagonist Therapeutics
PTGX
$9.48B
| – | – |
-303,429
| Closed | -$7.18M |
|
437
LiveRamp
RAMP
$2.29B
| – | – |
-105,750
| Closed | -$3.95M |
|
438
Resideo Technologies
REZI
$2.9B
| – | – |
-58,805
| Closed | -$1.4M |
|
439
Regions Financial
RF
$25.7B
| – | – |
-344,122
| Closed | -$7.66M |
|
440
Stellantis
STLA
$15.2B
| – | – |
-878,748
| Closed | -$16.4M |
|
441
TSMC
TSM
$2.17T
| – | – |
-91,458
| Closed | -$9.54M |
|
442
Twilio
TWLO
$35.5B
| – | – |
-554,902
| Closed | -$91.5M |
|
443
Unity
U
$19B
| – | – |
-1,010,656
| Closed | -$100M |
|
444
Upstart Holdings
UPST
$2.53B
| – | – |
-41,350
| Closed | -$4.51M |
|
445
Vericel Corp
VCEL
$2.01B
| – | – |
-8,814
| Closed | -$337K |
|
446
Vicor
VICR
$8.6B
| – | – |
-3,427
| Closed | -$242K |
|
447
Vishay Intertechnology
VSH
$4.89B
| – | – |
-11,398
| Closed | -$223K |
|
|
WBS
448
DELISTED
Webster Financial
WBS
| – | – |
-140,012
| Closed | -$7.86M |
|
449
Zimmer Biomet
ZBH
$18.4B
| – | – |
-144,936
| Closed | -$18.5M |
|
|
ZUO
450
DELISTED
Zuora, Inc.
ZUO
| – | – |
-409,021
| Closed | -$6.13M |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q2 2022 Portfolio in Review
As of Q2 2022, Polar Capital Holdings held 494 positions worth $17B, down 23% from $22.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Polar Capital Holdings withdrew a net $794M in Q2 2022, closing 61 positions and reducing 156 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Polar Capital Holdings opened a new position in Sanofi worth $36.3M.
- Polar Capital Holdings's largest Q2 2022 buy was Sanofi: 725,000 shares worth $36.3M.
- Polar Capital Holdings added most to Salesforce in Q2 2022, an estimated $108M increase.
- Polar Capital Holdings's biggest Q2 2022 reduction was Applied Materials, cutting an estimated $116M.
- Polar Capital Holdings fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, selling an estimated $147M.
- Polar Capital Holdings's ten largest holdings make up 43% of its $17B portfolio in Q2 2022.
- Polar Capital Holdings opened 36 new positions and closed 61 in Q2 2022.
- Polar Capital Holdings's portfolio value fell 23% quarter-over-quarter to $17B.
Based on Polar Capital Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.